Alzheimer’s OC to Present at Aging in America Conference 2018

Discussing the challenges and opportunities to tackle aging issues By Staff Blogger/ January, 2018 As more and more of us are living longer, there are increased opportunities and challenges that each community needs to plan for. Here in Orange County, our population is growing older faster than the national average. According to U.S. Census Bureau,

2018-02-27T16:52:43-08:00January 18th, 2018|Events|

AOC’s Accomplishments in 2017

Another successful year of helping families face Alzheimer’s and Dementia By Staff Blogger/ January, 2018 At Alzheimer’s Orange County (AOC), 2017 marks the end of another successful year of providing free services and programs to the Alzheimer’s community in Orange County. We are extremely grateful to our supporters, generous donors, and our incredible staff for

2018-01-23T11:40:42-08:00January 11th, 2018|Programs and Services|

Crenezumab Now in Phase-III of Development

By Charles S. Wilcox, Ph.D/ November, 2017                                  Since the approval of Namenda in 2003, there has not been any new and novel medication approved for the treatment of mild-to-moderate, or moderate-to-severe Alzheimer’s disease. During these subsequent fourteen years, there has

2018-01-23T11:35:05-08:00November 30th, 2017|Clinical Research|

Alzheimer’s Best Friend during Holidays

By Staff Blogger/November, 2017 With all of its pleasures, the holiday season can also be a time of loss and stress for families and individuals who are dealing with Alzheimer’s or dementia. However, there are ways to make the holidays a memorable and enjoyable season for all. David Troxel, an internationally known expert and speaker

2018-01-22T14:12:55-08:00November 23rd, 2017|Events|

Why We Miss the Mild Stage of Alzheimer’s

By Dr. Trinh/ November, 2017 There are three main stages of Alzheimer’s progression: the mild stage, the moderate stage, and the severe stage.  Prior to these three stages of the disease is a pre-Alzheimer’s stage, called “Mild Cognitive Impairment” (MCI). During MCI, individuals may occasionally experience memory problems which do not affect their activities of

2018-01-23T11:52:38-08:00November 16th, 2017|Clinical Research|

A New Direction in Alzheimer’s Treatment

By Dr. Trinh/ November, 2017 In neuroscience research, a new direction in Alzheimer’s clinical trials is to detect the disease early enough to possibly prevent it from progressing. Now, more and more research companies, including Irvine Clinical Research (ICR), are shifting their focus to trying to find and identify Alzheimer’s while symptoms are still mild

2018-01-23T11:30:18-08:00November 7th, 2017|Clinical Research|